NCT07007988View on ClinicalTrials.gov

A Phase I Study of SIM0388 in Participants With Malignant Ascites.

PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 24, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Malignant Ascites
Interventions
DRUG

SIM0388

Abdominal perfusion

DRUG

SIM0388

Abdominal perfusion

Trial Locations (1)

200131

RECRUITING

Shanghai Gobroad Cancer Hospital, Shanghai

Sponsors
All Listed Sponsors
lead

Jiangsu Simcere Pharmaceutical Co., Ltd.

INDUSTRY